참가업체 상세내용
| 디렉토리

자카르타 국제 프리미엄 소비재전

2023-09-14 ~ 2023-09-17 JCC, 인도네시아

업체정보
업체로고
업체명
(국문) (주)메타신
(en) Metacine, Inc.
홈페이지
www.metacineshop.com
소개
(국문) Metacine, Inc. has been preparing for the future by entering the global market with rhinitis treatment package products since its establishment and growth as a specialized biomedical and devices company in July 2010. The workplaces located in Wonju and Osong High-tech Medical Complex in Cheongju cities manage and supervise all processes from manufacturing production to marketing.
(en) Metacine, Inc. has been preparing for the future by entering the global market with rhinitis treatment package products since its establishment and growth as a specialized biomedical and devices company in July 2010. The workplaces located in Wonju and Osong High-tech Medical Complex in Cheongju cities manage and supervise all processes from manufacturing production to marketing.

출품제품정보
제품사진
제품

LasRhina - Rhinitis Treatment Medical Device

1. Purpose of development - A medical device used for rhinitis treatment using a laser beam with an energy density of less than 20J/cm^2 or 2W/cm^2 by irradiating a 650nm low-power laser into the nasal cavity 2. Appearance - As a premium product, it is a next-generation rhinitis treatment medical device that visualizes the progress of control and treatment using the application as a form of a nasal probe with an aesthetic product design suitable for the current trend and a lightweight, stable nose mount function. 3. Indications - Runny nose, stuffy nose, sneezing, itchy nose

제품사진
제품

atomemoRhina - Rhinitis Symptoms Improvement Mist

1. This mist is a natural product-derived cosmetic, so it is harmless even if it passes into the body, and there is little burden even after long-term use. Anyone from children to adults can easily spray it and use it whenever necessary. 2. This product has secured safety by using and manufacturing O-CNF (Cellulose Nano Fibril) over 200 nanometers in size and ingredients derived from natural products. O-CNF penetrates deep into the dermal layer of the skin through the complex action of glucose and ATM-1 (Patent Registration No. 10-1614659, Korea, 2016) and then reduces to normal skin tissue.

제품사진
제품



이벤트정보
현재 등록된 내용이 없거나 준비중일 수 있습니다.